Table 1 |
|
|
Characteristics of subjects |
|
|
Characteristic |
Value (n = 13) |
|
|
|
|
Sex (F/M) |
3/10 |
|
Age (years) |
|
|
Overall |
56.1 (40–75) |
|
Females |
64.7 (63–66) |
|
Males |
53.5 (40–75) |
|
No. of subjects with tophi |
11 |
|
No. of subjects on medication |
|
|
Allopurinol |
6 |
|
Uricosurics |
0 |
|
Colchicine |
3 |
|
Prednisone (for gout) |
8 |
|
Serum uric acid (mg/dl) |
|
|
Overall |
10.1 ± 2.3 (6.9–14.7) |
|
On allopurinol |
10.0 ± 2.4 (6.9–14.7) |
|
Not on allopurinol |
10.3 ± 2.3 (7.1–13.8) |
|
Serum creatinine (mg/dl) |
1.6 ± 0.5 (0.9–2.5) |
|
No. of subjects with co-morbidity |
|
|
Osteoarthritis |
3 |
|
Hypertension |
7 |
|
Heart disease |
2 |
|
Diabetes |
1 |
|
|
|
|
Where errors are shown, results are means ± SD; numbers in parentheses are ranges. Serum uric acid and serum creatinine were measured before allopurinol washout. |
|
|
Ganson et al. Arthritis Research & Therapy 2006 8:R12 doi:10.1186/ar1861 |
|
